Data / Medical devices / United States / Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc.: FDA-registered device maker in Carlsbad, CA, United States, 24 510(k) clearances
Ortho-Clinical Diagnostics, Inc. is registered with the FDA (registration 3021090658) in Carlsbad, CA, United States. It lists 21 device types. The FDA files 24 510(k) clearances under its listings, the newest dated March 22, 2024. 1 recall event names it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3021090658
- Address
- 2285 Rutherford Road, Carlsbad, CA, United States, 92008
- Owner or operator
- QuidelOrtho Corporation (2024674)
- Roles
- Complaint file establishment, Manufacturer, Manufacturer for export
- First device listed
- December 22, 1992
- Registered through
- 2026
- Brand names listed
- CVS Health At Home COVID-19 Test Kit, InflammaDry, QUICKVUE IFOB TEST, QuickVue Adenoviral conjunctivitis Test, QuickVue At Home COVID-19, QuickVue COVID-19 Test, QuickVue COVID-19 Test Control Swab Set, QuickVue Dipstick Strep A and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| March 22, 2024 | K231795 | QuickVue COVID-19 Test | QYT | Substantially Equivalent | Quidel Corporation | accessdata.fda.gov |
| December 13, 2023 | K233688 | Sofia 2 SARS Antigen+ FIA; Sofia 2 SARS Antigen+ FIA Control Swab Set | QVF | Substantially Equivalent | Quidel Corporation | accessdata.fda.gov |
| March 8, 2023 | DEN220039 | Sofia 2 SARS Antigen+ FIA, Sofia 2 SARS Antigen+ FIA Control Swab Set | QVF | Unknown | Quidel Corporation | accessdata.fda.gov |
| November 23, 2021 | K211342 | Sofia 2 Campylobacter FIA | LQP | Substantially Equivalent | Quidel Corporation | accessdata.fda.gov |
| August 30, 2018 | K173496 | Sofia 2 Lyme FIA, Sofia Lyme Control Set | LSR | Substantially Equivalent | Quidel Corporation | accessdata.fda.gov |
| October 20, 2017 | K163713 | Sofia Lyme FIA, Sofia Lyme Control Set | LSR | Substantially Equivalent | Quidel Corporation | accessdata.fda.gov |
| February 22, 2017 | K162911 | Sofia RSV FIA on Sofia 2 analyzer | GQG | Substantially Equivalent | Quidel Corporation | accessdata.fda.gov |
| December 16, 2014 | K141775 | SOFIA (R) STREP A+ FIA | GTY | Substantially Equivalent | Quidel Corporation | accessdata.fda.gov |
| November 21, 2013 | K132066 | INFLAMMA DRY | PFQ | Substantially Equivalent | Rapid Pathogen Screening, Inc. | accessdata.fda.gov |
| August 13, 2013 | K130398 | SOFIA(R) RSV FIA | GQG | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| October 24, 2011 | K112177 | SOFIA ANALYZER AND INFLUENZA A+B FIA | PSZ | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| May 17, 2011 | K110722 | RPS ADENO DETECTOR PLUS | GOD | Substantially Equivalent | Rapid Pathogen Screening, Inc. | accessdata.fda.gov |
| April 23, 2007 | K070747 | QUICK VUE RSV TEST, MODELS 20193, 20199 | GQG | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| December 14, 2005 | K053146 | QUICKVUE INFLUENZA A + B TEST | PSZ | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| June 17, 2002 | K021423 | INSTANT-VIEW FECAL OCCULT BLOOD RAPID TEST | KHE | Substantially Equivalent | Alfa Scientific Designs, Inc. | accessdata.fda.gov |
| May 17, 2002 | K020801 | QUICKVUE ONE-STEP HCG-COMBO | JHI | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| May 17, 2002 | K020799 | QUICKVUE ONE-STEP HCG-URINE | JHI | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| May 8, 2001 | K011097 | QUICKVUE DIPSTICK STREP A | GTY | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| November 26, 1997 | K973858 | CARDS Q.S. HCG SERUM/URINE;CONCISE PERFORMANCE PLUS HCG-COMBO | JHI | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| April 15, 1996 | K955108 | CARDS Q.S. STREP A | GTZ | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| February 10, 1995 | K945080 | QUICKVUE IN-LINE ONE-STEP STREP A CONTROL SWABS (POSITIVE & NEGATIVE SWAB SPECIMENS) | GTY | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| July 18, 1994 | K934484 | QUICKVUE IN-LINE ONE-STEP STREP A TEST | GTZ | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| June 22, 1993 | K931761 | QUICKVUE(TM) ONE-STEP HCG CONTROLS (POSIT/NEGATI) | JJX | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
| August 7, 1991 | K912868 | GROUP A STREP POSITIVE AND NEGATIVE CONTROLS | GTZ | Substantially Equivalent | Quidel Corp. | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| January 3, 2024 | 93799 | Class II | Ongoing | The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 to detect nucleocapsid protein from influenza A, influenza B, and SARS-CoV-2. This test allows for t | One lot of the Sofia 2 Flu + SARS Antigen FIA (Lot 709083) was labelled with incorrect expiration dates. The kits contain pouched cassettes labeled with an expiration date of May 31, 2025, however the correct expiration date for the pouches is September 12, 2024. The kits are labeled with an expiration date of April 30, 2025, however, the correct expiration | accessdata.fda.gov |
Compare with other makers
- All makers of Devices Detecting Influenza A, B, And C Virus Antigens
- All makers of Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus
- All makers of Antisera, All Groups, Streptococcus Spp.
- All makers of Fluorometer, For Clinical Use
- All makers of Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
- All makers of Reagent, Occult Blood
Updated March 22, 2024. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.